PUMA BIOTECHNOLOGY, INC. Increase (Decrease) in Other Current Assets
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Increase (Decrease) in Other Current Assets of -$57.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $3.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$60.00K, a 957.14% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $26.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $157.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for fiscal 2025 was $165.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for fiscal 2024 was -$821.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for fiscal 2023 was -$1.52M, a 176.54% decline from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other current assets for fiscal 2022 was $1.98M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$57.00K 10-Q · filed 2026-08-06 | -$31.00K derived: sum of 3 quarters · filed 2026-08-06 | $126.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$60.00K 10-Q · filed 2026-05-07 | -$34.00K derived: sum of 2 quarters · filed 2026-05-07 | $123.00K derived: sum of 3 quarters · filed 2026-05-07 | $98.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $183.00K derived: sum of 2 quarters · filed 2026-02-26 | $158.00K derived: sum of 3 quarters · filed 2026-08-06 | $165.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $132.00K derived: sum of 2 quarters · filed 2026-08-06 | $139.00K 10-Q · filed 2025-11-06 | -$6.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$18.00K 10-Q · filed 2026-08-06 | -$163.00K derived: sum of 3 quarters · filed 2026-08-06 | -$168.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-07 | -$138.00K derived: sum of 2 quarters · filed 2026-05-07 | -$143.00K derived: sum of 3 quarters · filed 2026-05-07 | -$157.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$150.00K derived: sum of 2 quarters · filed 2026-02-26 | -$164.00K derived: sum of 3 quarters · filed 2026-02-26 | -$821.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$19.00K derived: sum of 2 quarters · filed 2025-11-06 | -$676.00K 10-Q · filed 2025-11-06 | -$1.75M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$671.00K 10-Q · filed 2025-08-07 | -$1.75M derived: sum of 3 quarters · filed 2026-02-26 | -$332.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$657.00K 10-Q · filed 2025-05-08 | -$1.73M derived: sum of 2 quarters · filed 2026-02-26 | -$318.00K derived: sum of 3 quarters · filed 2026-02-26 | -$194.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $339.00K derived: sum of 2 quarters · filed 2026-02-26 | $463.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.52M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.54M derived: sum of 2 quarters · filed 2024-11-07 | -$441.00K 10-Q · filed 2024-11-07 | -$2.12M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$1.86M 10-Q · filed 2024-08-01 | -$3.54M derived: sum of 3 quarters · filed 2025-02-27 | -$3.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.98M 10-Q · filed 2024-05-02 | -$3.66M derived: sum of 2 quarters · filed 2025-02-27 | -$3.84M derived: sum of 3 quarters · filed 2025-02-27 | -$182.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.86M derived: sum of 2 quarters · filed 2025-02-27 | $1.80M derived: sum of 3 quarters · filed 2025-02-27 | $1.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.48M derived: sum of 2 quarters · filed 2023-11-02 | $3.66M 10-Q · filed 2023-11-02 | $3.66M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.84M 10-Q · filed 2023-08-03 | $3.84M derived: sum of 3 quarters · filed 2024-02-29 | $3.81M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $184.00K 10-Q · filed 2023-05-04 | $180.00K derived: sum of 2 quarters · filed 2024-02-29 | $153.00K derived: sum of 3 quarters · filed 2024-02-29 | $258.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$31.00K derived: sum of 2 quarters · filed 2024-02-29 | $74.00K derived: sum of 3 quarters · filed 2024-02-29 | -$3.19M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $78.00K derived: sum of 2 quarters · filed 2022-11-03 | -$3.19M 10-Q · filed 2022-11-03 | -$3.17M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.16M 10-Q · filed 2022-08-04 | -$3.15M derived: sum of 3 quarters · filed 2023-03-02 | -$3.15M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$3.27M 10-Q · filed 2022-05-05 | -$3.25M derived: sum of 2 quarters · filed 2023-03-02 | -$3.25M derived: sum of 3 quarters · filed 2023-03-02 | -$130.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $17.00K derived: sum of 2 quarters · filed 2023-03-02 | $3.14M derived: sum of 3 quarters · filed 2023-03-02 | $3.12M 10-K · filed 2023-03-02 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.12M derived: sum of 2 quarters · filed 2021-11-04 | $3.10M 10-Q · filed 2021-11-04 | $3.10M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.10M 10-Q · filed 2021-08-05 | $3.10M derived: sum of 3 quarters · filed 2022-03-03 | $3.10M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | -$18.00K 10-Q · filed 2021-05-06 | -$17.00K derived: sum of 2 quarters · filed 2022-03-03 | -$25.00K derived: sum of 3 quarters · filed 2022-03-03 | -$9.85M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$7.00K derived: sum of 2 quarters · filed 2022-03-03 | -$9.83M derived: sum of 3 quarters · filed 2022-03-03 | -$1.46M 10-K · filed 2022-03-03 |
| 2019-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$9.83M derived: sum of 2 quarters · filed 2020-11-05 | -$1.47M 10-Q · filed 2020-11-05 | -$11.17M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$9.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.46M 10-Q · filed 2020-08-06 | -$11.16M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $8.37M 10-Q · filed 2020-05-07 | -$1.34M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.79M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $11.49M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |